Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Strepfen Intensive |
Active Ingredient: | Flurbiprofen 16.2mg/mL equivalent to 8.748mg per dose |
Dosage Form: | Oral spray |
New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
Manufacturer: | Reckitt Benckiser Healthcare Manufacturing (Thailand) Limited, Bangplee, Thailand |
Product: | Strepsils Plus Anaesthetic Throat Spray |
Active Ingredients: | Amylmetacresol 0.223%w/v Dichlorobenzyl alcohol 0.446%w/v Lidocaine 0.6%w/v |
Dosage Form: | Oral spray |
New Zealand Sponsor: | Reckitt Benckiser (New Zealand) Limited |
Manufacturer: | Delpharm Bladel B.V., Bladel, Netherlands |
Dated this 8th day of October 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).